Keith J. C. Darragh

Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT.

Vision-Sciences, Inc. designs, develops, manufactures, and markets products for endoscopy to provide minimally invasive access to areas not readily visible to the human eye. It operates through two reportable segments: Medical and Industrial. The Medical segment designs, manufactures and sells its advanced line of endoscopy based products for a variety of specialties, including state-of-the-art flexible endoscopes, and Slide-On EndoSheath technology. The Industrial segment designs, manufactures and sells borescopes to a variety of users, primarily in the aircraft engine manufacturing and aircraft engine maintenance industries. The company was founded by Lewis C. Pell and Katsumi Oneda in 1987 and is headquartered in Orangeburg, NY.

Datascope Corp. manufactures and distributes surgical equipments. The company provides medical instruments such as intra aortic balloon pumps and catheters for use in cardiology, radiology, anesthesiology, cardiovascular, vascular surgery and emergency medicine. It also develops vascular grafts and patches for reconstructive blood vessel surgeries as well as multifunction patient monitoring devices. The company was founded in 1964 as New York Corp. It is headquartered in Montvale, NJ.

Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA.